Sotiriou, S.; Samara, A.A.; Vamvakopoulou, D.; Vamvakopoulos, K.-O.; Sidiropoulos, A.; Vamvakopoulos, N.; Janho, M.B.; Gourgoulianis, K.I.; Boutlas, S.
Susceptibility of β-Thalassemia Heterozygotes to COVID-19. J. Clin. Med. 2021, 10, 3645.
https://doi.org/10.3390/jcm10163645
AMA Style
Sotiriou S, Samara AA, Vamvakopoulou D, Vamvakopoulos K-O, Sidiropoulos A, Vamvakopoulos N, Janho MB, Gourgoulianis KI, Boutlas S.
Susceptibility of β-Thalassemia Heterozygotes to COVID-19. Journal of Clinical Medicine. 2021; 10(16):3645.
https://doi.org/10.3390/jcm10163645
Chicago/Turabian Style
Sotiriou, Sotirios, Athina A. Samara, Dimitra Vamvakopoulou, Konstantinos-Odysseas Vamvakopoulos, Andreas Sidiropoulos, Nikolaos Vamvakopoulos, Michel B. Janho, Konstantinos I. Gourgoulianis, and Styllianos Boutlas.
2021. "Susceptibility of β-Thalassemia Heterozygotes to COVID-19" Journal of Clinical Medicine 10, no. 16: 3645.
https://doi.org/10.3390/jcm10163645
APA Style
Sotiriou, S., Samara, A. A., Vamvakopoulou, D., Vamvakopoulos, K.-O., Sidiropoulos, A., Vamvakopoulos, N., Janho, M. B., Gourgoulianis, K. I., & Boutlas, S.
(2021). Susceptibility of β-Thalassemia Heterozygotes to COVID-19. Journal of Clinical Medicine, 10(16), 3645.
https://doi.org/10.3390/jcm10163645
